TINA SAJADI: Open Payments
NPI 1952061202 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 10 payments from 6 companies in 2025. Trend: 2023 $24 · 2024 $1,345 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $114 |
| Novo Nordisk Inc | 3 | $71 |
| Lilly USA, LLC | 2 | $37 |
| Amgen Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $14 |
Products named: BREZTRI, MOUNJARO, Ozempic, KRYSTEXXA, FANAPT, Wegovy, Rybelsus, FARXIGA.
Industry payments across NV — which companies pay providers there.
